In mild patients, oral salicylazosulfapyridine (SASP) or 5-aminosalicylic acid (5-ASA) was given as the primary medical therapy.

• 内科治疗轻度患者以口服柳氮磺胺吡啶(SASP)/5-氨基水杨酸(5-ASA)为主；